A study on the fate of curcumin in the rat.
By Bo Wahlström, G. Blennow. Acta Pharmacologica et Toxicologica, 2009
623 citations recorded by the source corpus.
Subfields: Molecular Biology, Molecular Medicine, Pharmacology
View Paper: https://www.semanticscholar.org/paper/39ccb20af458ea19e6ada8b1a1a7158298002775
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- Bharat B. Aggarwal
- A. Kunnumakkara
- K. Priyadarsini
- Ricky A. Sharma
- N. Škalko-Basnet
- P. Basnet
- K. Harikumar
- P. Anand
In Molecular Medicine
- Bharat B. Aggarwal
- A. Kunnumakkara
- K. Priyadarsini
- Ricky A. Sharma
- N. Škalko-Basnet
- P. Basnet
- A. Goel
- P. Anand
In Pharmacology
- Bharat B. Aggarwal
- A. Kunnumakkara
- K. Priyadarsini
- N. Škalko-Basnet
- A. Goel
- P. Basnet
- P. Anand
- Raghavendhar R. Kotha
Citations in the corpus
- Curcumin: An Anti-Inflammatory Molecule from a Curry Spice on the Path to Cancer Treatment (2011, background): “75% of the dose being excreted in faeces and negligible amounts were detected in the urine [38].”
- Curcumin: the story so far. (2005, neutral): “Studies of curcumin in animals have confirmed a lack of significant toxicity since an early report in which doses up to 5 g/kg were administered orally to Sprague–Dawley rats [16].”
- The Chemistry of Curcumin: From Extraction to Therapeutic Agent (2014, background): “The metabolism of curcumin in rats and humans produces different products [49–53].”
- Regulation of inflammation and redox signaling by dietary polyphenols. (2006, background): “Pharmacokinetic measurements have revealed that about 40– 85% of ingested curcumin is unaltered in the gastrointestinal tract, most of the absorbed flavonoid being metabolized in the intestinal mucosa and liver [11].”
- Curcumin: Preventive and Therapeutic Properties in Laboratory Studies and Clinical Trials (2008, neutral): “In the first published study, a dose of 1 g/kg was administered orally to rats, resulting in (cid:2) 75% of the dose being excreted in the feces, and negligible amounts appearing in the urine (271).”
- Multiple biological activities of curcumin: a short review. (2006, background): “…was shown that oral consumption of curcumin in rats resulted in approximately 75% being excreted in the feces and only traces appeared in the urine (Wahlstrom and Blennow, 1978), whereas intra-peritoneal (i.p) administration accounted for similar levels of fecal excretion of curcumin, with only…”
- Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. (2001, background): “4 179 (100); 165 (16); 193 (17); 373 (10) Hepatocyte metabolite 2 22.”
- Curcumin as "Curecumin": from kitchen to clinic. (2008, background): “As several groups have shown, the liver appears to be the major organ responsible for metabolism of curcumin [150,156,157].”
- Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. (2001, background): “In rodents, curcumin undergoes avid metabolism by conjugation and reduction, and its disposition after oral dosing is characterized by poor systemic bioavailability (9, 17, 19, 20).”